News Conference News ACC 2026 Clinician EHR Alerts Lead to Speedier Evaluation, Treatment of Valve Disease Todd Neale April 01, 2026
News Conference News ACC 2026 Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV Caitlin E. Cox March 30, 2026
News Conference News ACC 2026 Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3 Yael L. Maxwell March 29, 2026
Presentation ACC 2026 Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation Presenter: Erwan Donal March 29, 2026
News Daily News US Societies Lay Out Requirements for Transcatheter Tricuspid Valve Procedures Michael O'Riordan March 27, 2026
News Daily News FDA Approves JenaValve’s Trilogy for Aortic Regurgitation Michael O'Riordan March 23, 2026
News Conference News THT 2026 Should Moderate FMR Be Treated With M-TEER? Experts Duke It Out Todd Neale March 06, 2026
News Conference News THT 2026 NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER Todd Neale March 04, 2026
Presentation THT 2026 LAVA ECMO Support in Severe Mitral Regurgitation as a Bridge to Mitral Valve Repair Presenter: Som Singh March 04, 2026
Presentation THT 2026 Over-Reliance on echocardiogram: A story of missed TAVR failure aortic regurgitation. Presenter: Norman Zheng March 04, 2026
Presentation THT 2026 Preclinical Results of a Novel, Percutaneous Device to Reapproximate and Reshape the Right Ventricle in Functional Tricuspid Regurgitation with Right Ventricular Dysfunction Presenter: Michael I. Brener March 03, 2026
Presentation THT 2026 Early Human Feasibility Experience with a Novel Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Functional Mitral Regurgitation in Heart Failure reduced Ejection Fraction Presenter: Edwin Ho March 03, 2026
Presentation THT 2026 Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER Presenter: Thitiphan Srikulmontri March 03, 2026
Presentation THT Abstracts 2026 A Retrospective Analysis of Heart Failure Hospitalization Trends in Patients with Functional Mitral Regurgitation in a Real-world Clinical Setting Presenter: Colin Barker March 02, 2026
Presentation THT Abstracts 2026 Baseline NT-proBNP Predicts Outcomes After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation with Preserved Ejection Fraction: The REPAIR Study Presenter: Philipp von Stein March 02, 2026
News Daily News Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN Yael L. Maxwell February 26, 2026
News Daily News Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial Michael O'Riordan February 19, 2026
News Daily News Meta-analysis Teases Out What Drives Success in M-TEER Caitlin E. Cox February 10, 2026
News Daily News Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators Michael O'Riordan January 22, 2026